Stanich Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$292K Hold
252
– – 0.14% 49
2026
Q2
$302K Buy
252
+17
+7% +$17.4K 0.19% 38
2026
Q1
$216K Hold
235
– – 0.16% 43
2025
Q4
$253K Buy
+235
New +$225K 0.19% 38

Other funds holding LLY

Stanich Group's LLY Position: Q3 2026 in Review

Stanich Group held its Eli Lilly (LLY) position steady in Q3 2026 at 252 shares worth $292K. The position accounts for 0.14% of the portfolio, ranked #49.

Stanich Group first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $302K in Q2 2026. 1,032 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Stanich Group held 252 shares of Eli Lilly worth $292K as of Q3 2026.
  • Stanich Group left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.14% of Stanich Group's portfolio in Q3 2026, its #49 holding.
  • Stanich Group first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Stanich Group's Eli Lilly position peaked at $302K in Q2 2026.
  • 1,032 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Stanich Group's 13F filing for Q3 2026, filed 16 Oct 2026.